Marks Group Wealth Management’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,690	Closed	-$726K	–	282
2022 Q3	$726K	Buy	3,690 +119	+3%	+$25.7K	0.11%	176
2022 Q2	$764K	Buy	3,571 +137	+4%	+$33.5K	0.11%	184
2022 Q1	$975K	Buy	3,434 +216	+7%	+$66.6K	0.12%	168
2021 Q4	$1.24M	Sell	3,218 -6	-0.2%	-$2.33K	0.15%	147
2021 Q3	$1.31M	Sell	3,224 -83	-3%	-$34.5K	0.18%	134
2021 Q2	$1.2M	Sell	3,307 -38	-1%	-$12.7K	0.16%	137
2021 Q1	$980K	Buy	3,345 +67	+2%	+$18.6K	0.15%	140
2020 Q4	$819K	Buy	3,278 +137	+4%	+$32.6K	0.13%	148
2020 Q3	$711K	Buy	3,141 +117	+4%	+$24.3K	0.13%	149
2020 Q2	$534K	Sell	3,024 -3,541	-54%	-$565K	0.11%	156
2020 Q1	$867K	Buy	6,565 +224	+4%	+$33.6K	0.22%	123
2019 Q4	$969K	Buy	+6,341	New	+$878K	0.19%	141